Zobrazeno 1 - 10 of 50 pro vyhledávání: '"M E Erwin"'
1
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program
Autor: M E Erwin, Angela B. Brueggemann, GaryV Doern, R N Jones, M. A. Pfaller
As part of the SENTRY antimicrobial resistance surveillance program, a total of 1100 clinically significant respiratory tract isolates of Streptococcus pneumoniae were tested for susceptibility to six fluoroquinolone antimicrobial agents: ciprofloxac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2f15e81ad81a5b4587c07e36f32908a
https://doi.org/10.1016/s0732-8893(98)00081-9
Zobrazit plný text záznamu
2
Avaliação da sensibilidade a antimicrobianos de 87 amostras clínicas de enterococos resistentes à vancomicina
Autor: I.h. Saraiva, R N Jones, Helio S. Sader, M E Erwin
Publikováno v: Revista da Associação Médica Brasileira, Vol 43, Iss 3, Pp 217-222 (1997)
Revista da Associação Médica Brasileira v.43 n.3 1997
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
OBJECTIVES. 1) To evaluate the antimicrobial susceptibility pattern of vancomycin-resistant enterococci to the antimicrobial agents that are commonly used to treat enterococci infections and to some alternative drugs. 2) To evaluate the accuracy of E
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cda7d43b9e4514a3dc5ffecc1913b80
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42301997000300009&tlng=pt
Zobrazit plný text záznamu
3
Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium
Autor: M E Erwin, Gary V. Doern, Janet F. Hindler, E. H. Gerlach, R N Jones
Publikováno v: Diagnostic Microbiology and Infectious Disease. 18:243-249
Some recently marketed macrolide antimicrobial agents possess physiochemical, antimicrobial, and pharmacokinetic advantages that enable their wider clinical use against Haemophilus influenzae infections. A five-laboratory study assessed the validity
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3c66dd3bc50b3a94600e07c71549d7f9
https://doi.org/10.1016/0732-8893(94)90027-2
Zobrazit plný text záznamu
4
In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compounds
Autor: Mary S. Barrett, R N Jones, M E Erwin
Publikováno v: European Journal of Clinical Microbiology & Infectious Diseases. 12:134-141
The compound E-4868 (Laboratorios Dr. Esteve) is a trifluoro, 7-azetidinyl quinolone with properties resembling those of other fluoroquinolones. Its activity in vitro was compared to that of six other similar drugs against more than 700 nosocomial is
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eef163108b47e01bd248782e4c36e02
https://doi.org/10.1007/bf01967592
Zobrazit plný text záznamu
6
Ofloxacin, a new broad-spectrum fluoroquinolone results from a multicenter, national comparative activity surveillance study
Autor: L B Reller, Martha L. Sanchez, L A Rosati, R N Jones, M E Erwin
Publikováno v: Diagnostic Microbiology and Infectious Disease. 15:425-434
Ofloxacin, a newer broad-spectrum fluoroquinolone, was evaluated against 6967 clinical isolates in a multicenter surveillance trial using a standardized disk diffusion method. Thirty-five geographically diverse laboratories contributed zone diameter
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::89933dcbfee8130e50dbbe14b1b20443
https://doi.org/10.1016/0732-8893(92)90084-7
Zobrazit plný text záznamu
7
In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones
Autor: M E Erwin, R N Jones, Helio S. Sader
Publikováno v: European Journal of Clinical Microbiology & Infectious Diseases. 11:372-381
The in vitro activity of OPC-17116 was compared to that of five similar fluoroquinolones (ciprofloxacin, enoxacin, norfloxacin, ofloxacin and temafloxacin). A total of 700 isolates from recent cases of clinical bacteremia were tested. Fifty additiona
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbad1d18cd32241be6a072344d63e3e2
https://doi.org/10.1007/bf01962081
Zobrazit plný text záznamu
8
In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin
Autor: M E Erwin, R N Jones
Publikováno v: Antimicrobial Agents and Chemotherapy. 36:233-238
Ro 09-1227 is a novel 7-position catechol-substituted parenteral cephalosporin that also has a 3-position radical similar to previously described cephems. The Ro 09-1227 spectrum was slightly wider than that of ceftazidime against members of the fami
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c30d79f991ef4a8661bea730b4c10b
https://doi.org/10.1128/aac.36.1.233
Zobrazit plný text záznamu
9
In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates
Autor: F P Koontz, Michael A. Pfaller, John A. Washington, R. N. Jones, S D Allen, M E Erwin, P R Murray, E. H. Gerlach
Publikováno v: Antimicrobial Agents and Chemotherapy. 35:1508-1511
The activity of GR69153, a novel catechol-substituted cephalosporin, was compared with those of ceftazidime and ceftriaxone in a multicenter study against 5,203 fresh clinical isolates of gram-negative and gram-positive bacteria. GR69153 was generall
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6533926084745f8a94b4e3ded1f9ceab
https://doi.org/10.1128/aac.35.7.1508
Zobrazit plný text záznamu
10
Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetan
Autor: C. C. Knapp, M. A. Pfaller, Franklin P. Koontz, E H Gerlach, R N Jones, P R Murray, M E Erwin, J A Washington
Publikováno v: Journal of Clinical Microbiology. 29:363-366
Cefotetan was tested in a multilaboratory study to standardize susceptibility testing criteria and quality control guidelines for Neisseria gonorrhoeae. Cefotetan was most active against penicillinase-producing and penicillin-susceptible strains (MIC
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcba3e0c121eaf5e5fe40b1c746a42b4
https://doi.org/10.1128/jcm.29.2.363-366.1991
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje